RNU6-202P

Across TCGA pan-cancer cohorts, RNU6-202P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNU6-202P’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RNU6-202P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6-202P is over-expressed in tumor.

STAD and LUSC are the cancer types where RNU6-202P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-202P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	II,III,IV	+0.369	.022	4	view →
LUSC	All	II,III,IV	+0.173	.023	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RNU6-202P–STAD

Open the STAD breakdown →